Length of Time between Product Exposure and Onset of Adverse Event Symptom
nci:P207
C2985138
nci:P322
FDA
nci:P90
<n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Length of Time between Product Exposure and Onset of Adverse Event Symptom</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm><n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>LENGTH OF TIME BETWEEN PRODUCT EXPOSURE AND ONSET OF ADVERSE EVENT SYMPTOM</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>FDA</n0:term-source></n0:ComplexTerm>
nci:P97
<n0:ComplexDefinition xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:def-definition>The duration of time from initial contact with a substance until the appearance of undesired symptoms.</n0:def-definition><n0:def-source>NCI</n0:def-source></n0:ComplexDefinition>